0.85 USD
↘ 0.01 (1.60%)AT CLOSE (03:59 PM EDT)
Pliant Therapeutics, Inc. Common Stock
PLRXNASDAQ • USD
0.86
↗ 0.01 (0.61%)
POST MARKET (AS OF 05:13 PM EDT)
Post Market
AS OF 05:13 PM EDT
0.86
↗ 0.01 (0.61%)
Market: CLOSED
Pliant Therapeutics, Inc. Common Stock (PLRX) trades at $0.85 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Oct 26, 2026.
Open?$0.87
High?$0.90
Low?$0.84
Prev. Close?$0.86
Volume?298.9K
Avg. Volume?402.9K
VWAP?$0.85
Rel. Volume?0.74x
Bid / Ask
Bid?$0.72 × 100
Ask?$1.01 × 100
Spread?$0.29
Midpoint?$0.87
Valuation & Ratios
Market Cap?53.3M
Shares Out?61.9M
Float?48.2M
Float %?77.8%
P/E Ratio?N/A
P/B Ratio?0.36
EPS?-$1.49
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Employees
49
Market Cap
53.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-06-03
Address
331 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-481-6770
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-481-6770
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?23
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.67Distress
Confidence?44%Low
Short InterestVery High
Short % of Float?9.62%Elevated
Short Interest?4.6M
Days to Cover?10.4
Free Float48.2M
Avg Daily Volume447.4K
Settlement Date2026-10-15
Financial Health
Current Ratio?9.90Strong
Quick Ratio?9.90Strong
Cash Ratio?1.51Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.36CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-62.8%WEAK▾
S&P3
ROA?-48.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-70895000
Enterprise Value?$28.4M
Fundamentals ratios updated end of day